1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Viremia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caini, P; Giannelli, F; Giannini, C; Gragnani, L; Guerra, CT; Laffi, G; Monti, M; Petrarca, A; Solazzo, V; Zignego, AL | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Viremia
| Article | Year |
|---|---|
Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antiviral Agents; Apolipoprotein B-100; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Macrophages; Male; Middle Aged; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Viremia | 2007 |